- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Biologic Therapeutic Drug will have significant change from previous year. By the most conservative estimates of global Biologic Therapeutic Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the Biologic Therapeutic Drug market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Therapeutic Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Clinical Medicine
Laboratory
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Aurobindo Pharma Ltd.
Concord Biotech
GlaxoSmithKline Plc.
H. Lundbeck A/S
Novartis Global
Retractable Technologies, Inc.
Smith Medical
AstraZeneca
Pfizer Inc.
Merck and Co. Inc.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biologic Therapeutic Drug Market Size 2016-2026
2.1.2 Biologic Therapeutic Drug Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Biologic Therapeutic Drug Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Monoclonal Antibodies
2.2.3 Vaccines
2.3 Biologic Therapeutic Drug Market Size by Type
2.3.1 Global Biologic Therapeutic Drug Market Size CAGR by Type
2.3.2 Global Biologic Therapeutic Drug Market Size Market Share by Type (2016-2021)
2.4 Biologic Therapeutic Drug Segment by Application
2.4.1 Clinical Medicine
2.4.2 Laboratory
2.4.3 Others
2.5 Biologic Therapeutic Drug Market Size by Application
2.5.1 Global Biologic Therapeutic Drug Market Size CAGR by Application
2.5.2 Global Biologic Therapeutic Drug Market Size Market Share by Application (2016-2021)
3 Biologic Therapeutic Drug Market Size by Players
3.1 Biologic Therapeutic Drug Market Size Market Share by Players
3.1.1 Global Biologic Therapeutic Drug Revenue by Players (2019-2021E)
3.1.2 Global Biologic Therapeutic Drug Revenue Market Share by Players (2019-2021E)
3.2 Global Biologic Therapeutic Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biologic Therapeutic Drug by Regions
4.1 Biologic Therapeutic Drug Market Size by Regions (2016-2021)
4.2 Americas Biologic Therapeutic Drug Market Size Growth (2016-2021)
4.3 APAC Biologic Therapeutic Drug Market Size Growth (2016-2021)
4.4 Europe Biologic Therapeutic Drug Market Size Growth (2016-2021)
4.5 Middle East & Africa Biologic Therapeutic Drug Market Size Growth (2016-2021)
5 Americas
5.1 Americas Biologic Therapeutic Drug Market Size by Country (2016-2021)
5.2 Americas Biologic Therapeutic Drug Market Size by Type (2016-2021)
5.3 Americas Biologic Therapeutic Drug Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologic Therapeutic Drug Market Size by Region (2016-2021)
6.2 APAC Biologic Therapeutic Drug Market Size by Type (2016-2021)
6.3 APAC Biologic Therapeutic Drug Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biologic Therapeutic Drug by Country (2016-2021)
7.2 Europe Biologic Therapeutic Drug Market Size by Type (2016-2021)
7.3 Europe Biologic Therapeutic Drug Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biologic Therapeutic Drug by Region (2016-2021)
8.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2016-2021)
8.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Biologic Therapeutic Drug Market Forecast
10.1 Global Biologic Therapeutic Drug Forecast by Regions (2021-2026)
10.1.1 Global Biologic Therapeutic Drug Forecast by Regions (2021-2026)
10.1.2 Americas Biologic Therapeutic Drug Forecast
10.1.3 APAC Biologic Therapeutic Drug Forecast
10.1.4 Europe Biologic Therapeutic Drug Forecast
10.1.5 Middle East & Africa Biologic Therapeutic Drug Forecast
10.2 Americas Biologic Therapeutic Drug Forecast by Countries (2021-2026)
10.2.1 United States Biologic Therapeutic Drug Market Forecast
10.2.2 Canada Biologic Therapeutic Drug Market Forecast
10.2.3 Mexico Biologic Therapeutic Drug Market Forecast
10.2.4 Brazil Biologic Therapeutic Drug Market Forecast
10.3 APAC Biologic Therapeutic Drug Forecast by Region (2021-2026)
10.3.1 China Biologic Therapeutic Drug Market Forecast
10.3.2 Japan Biologic Therapeutic Drug Market Forecast
10.3.3 Korea Biologic Therapeutic Drug Market Forecast
10.3.4 Southeast Asia Biologic Therapeutic Drug Market Forecast
10.3.5 India Biologic Therapeutic Drug Market Forecast
10.3.6 Australia Biologic Therapeutic Drug Market Forecast
10.4 Europe Biologic Therapeutic Drug Forecast by Country (2021-2026)
10.4.1 Germany Biologic Therapeutic Drug Market Forecast
10.4.2 France Biologic Therapeutic Drug Market Forecast
10.4.3 UK Biologic Therapeutic Drug Market Forecast
10.4.4 Italy Biologic Therapeutic Drug Market Forecast
10.4.5 Russia Biologic Therapeutic Drug Market Forecast
10.5 Middle East & Africa Biologic Therapeutic Drug Forecast by Region (2021-2026)
10.5.1 Egypt Biologic Therapeutic Drug Market Forecast
10.5.2 South Africa Biologic Therapeutic Drug Market Forecast
10.5.3 Israel Biologic Therapeutic Drug Market Forecast
10.5.4 Turkey Biologic Therapeutic Drug Market Forecast
10.5.5 GCC Countries Biologic Therapeutic Drug Market Forecast
10.6 Global Biologic Therapeutic Drug Forecast by Type (2021-2026)
10.7 Global Biologic Therapeutic Drug Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Aurobindo Pharma Ltd.
11.1.1 Aurobindo Pharma Ltd. Company Information
11.1.2 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Offered
11.1.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Aurobindo Pharma Ltd. Main Business Overview
11.1.5 Aurobindo Pharma Ltd. Latest Developments
11.2 Concord Biotech
11.2.1 Concord Biotech Company Information
11.2.2 Concord Biotech Biologic Therapeutic Drug Product Offered
11.2.3 Concord Biotech Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Concord Biotech Main Business Overview
11.2.5 Concord Biotech Latest Developments
11.3 GlaxoSmithKline Plc.
11.3.1 GlaxoSmithKline Plc. Company Information
11.3.2 GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Offered
11.3.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 GlaxoSmithKline Plc. Main Business Overview
11.3.5 GlaxoSmithKline Plc. Latest Developments
11.4 H. Lundbeck A/S
11.4.1 H. Lundbeck A/S Company Information
11.4.2 H. Lundbeck A/S Biologic Therapeutic Drug Product Offered
11.4.3 H. Lundbeck A/S Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 H. Lundbeck A/S Main Business Overview
11.4.5 H. Lundbeck A/S Latest Developments
11.5 Novartis Global
11.5.1 Novartis Global Company Information
11.5.2 Novartis Global Biologic Therapeutic Drug Product Offered
11.5.3 Novartis Global Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Novartis Global Main Business Overview
11.5.5 Novartis Global Latest Developments
11.6 Retractable Technologies, Inc.
11.6.1 Retractable Technologies, Inc. Company Information
11.6.2 Retractable Technologies, Inc. Biologic Therapeutic Drug Product Offered
11.6.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Retractable Technologies, Inc. Main Business Overview
11.6.5 Retractable Technologies, Inc. Latest Developments
11.7 Smith Medical
11.7.1 Smith Medical Company Information
11.7.2 Smith Medical Biologic Therapeutic Drug Product Offered
11.7.3 Smith Medical Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Smith Medical Main Business Overview
11.7.5 Smith Medical Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Biologic Therapeutic Drug Product Offered
11.8.3 AstraZeneca Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Information
11.9.2 Pfizer Inc. Biologic Therapeutic Drug Product Offered
11.9.3 Pfizer Inc. Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Pfizer Inc. Main Business Overview
11.9.5 Pfizer Inc. Latest Developments
11.10 Merck and Co. Inc.
11.10.1 Merck and Co. Inc. Company Information
11.10.2 Merck and Co. Inc. Biologic Therapeutic Drug Product Offered
11.10.3 Merck and Co. Inc. Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Merck and Co. Inc. Main Business Overview
11.10.5 Merck and Co. Inc. Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Biologic Therapeutic Drug Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Therapeutic Proteins
Table 4. Major Players of Vaccines
Table 5. Biologic Therapeutic Drug Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Biologic Therapeutic Drug Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Biologic Therapeutic Drug Market Size Market Share by Type (2016-2021)
Table 8. Biologic Therapeutic Drug Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Biologic Therapeutic Drug Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Biologic Therapeutic Drug Market Size Market Share by Application (2016-2021)
Table 11. Global Biologic Therapeutic Drug Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Biologic Therapeutic Drug Revenue Market Share by Players (2019-2021E)
Table 13. Biologic Therapeutic Drug Key Players Head office and Products Offered
Table 14. Biologic Therapeutic Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Biologic Therapeutic Drug Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Biologic Therapeutic Drug Market Size Market Share by Regions 2016-2021
Table 19. Americas Biologic Therapeutic Drug Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Biologic Therapeutic Drug Market Size Market Share by Country (2016-2021)
Table 21. Americas Biologic Therapeutic Drug Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Biologic Therapeutic Drug Market Size Market Share by Type (2016-2021)
Table 23. Americas Biologic Therapeutic Drug Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Biologic Therapeutic Drug Market Size Market Share by Application (2016-2021)
Table 25. APAC Biologic Therapeutic Drug Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Biologic Therapeutic Drug Market Size Market Share by Region (2016-2021)
Table 27. APAC Biologic Therapeutic Drug Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Biologic Therapeutic Drug Market Size Market Share by Type (2016-2021)
Table 29. APAC Biologic Therapeutic Drug Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Biologic Therapeutic Drug Market Size Market Share by Application (2016-2021)
Table 31. Europe Biologic Therapeutic Drug Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Biologic Therapeutic Drug Market Size Market Share by Country (2016-2021)
Table 33. Europe Biologic Therapeutic Drug Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Biologic Therapeutic Drug Market Size Market Share by Type (2016-2021)
Table 35. Europe Biologic Therapeutic Drug Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Biologic Therapeutic Drug Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Biologic Therapeutic Drug Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Biologic Therapeutic Drug Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Biologic Therapeutic Drug Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Biologic Therapeutic Drug Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Biologic Therapeutic Drug
Table 44. Key Application and Potential Industries of Biologic Therapeutic Drug
Table 45. Key Challenges of Biologic Therapeutic Drug
Table 46. Key Trends of Biologic Therapeutic Drug
Table 47. Global Biologic Therapeutic Drug Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Biologic Therapeutic Drug Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Biologic Therapeutic Drug Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Biologic Therapeutic Drug Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Biologic Therapeutic Drug Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Biologic Therapeutic Drug Market Size Market Share Forecast by Application (2021-2026)
Table 53. Aurobindo Pharma Ltd. Details, Company Type, Biologic Therapeutic Drug Area Served and Its Competitors
Table 54. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Offered
Table 55. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Aurobindo Pharma Ltd. Main Business
Table 57. Aurobindo Pharma Ltd. Latest Developments
Table 58. Concord Biotech Details, Company Type, Biologic Therapeutic Drug Area Served and Its Competitors
Table 59. Concord Biotech Biologic Therapeutic Drug Product Offered
Table 60. Concord Biotech Main Business
Table 61. Concord Biotech Biologic Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Concord Biotech Latest Developments
Table 63. GlaxoSmithKline Plc. Details, Company Type, Biologic Therapeutic Drug Area Served and Its Competitors
Table 64. GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Offered
Table 65. GlaxoSmithKline Plc. Main Business
Table 66. GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. GlaxoSmithKline Plc. Latest Developments
Table 68. H. Lundbeck A/S Details, Company Type, Biologic Therapeutic Drug Area Served and Its Competitors
Table 69. H. Lundbeck A/S Biologic Therapeutic Drug Product Offered
Table 70. H. Lundbeck A/S Main Business
Table 71. H. Lundbeck A/S Biologic Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. H. Lundbeck A/S Latest Developments
Table 73. Novartis Global Details, Company Type, Biologic Therapeutic Drug Area Served and Its Competitors
Table 74. Novartis Global Biologic Therapeutic Drug Product Offered
Table 75. Novartis Global Main Business
Table 76. Novartis Global Biologic Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Novartis Global Latest Developments
Table 78. Retractable Technologies, Inc. Details, Company Type, Biologic Therapeutic Drug Area Served and Its Competitors
Table 79. Retractable Technologies, Inc. Biologic Therapeutic Drug Product Offered
Table 80. Retractable Technologies, Inc. Main Business
Table 81. Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Retractable Technologies, Inc. Latest Developments
Table 83. Smith Medical Details, Company Type, Biologic Therapeutic Drug Area Served and Its Competitors
Table 84. Smith Medical Biologic Therapeutic Drug Product Offered
Table 85. Smith Medical Main Business
Table 86. Smith Medical Biologic Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Smith Medical Latest Developments
Table 88. AstraZeneca Details, Company Type, Biologic Therapeutic Drug Area Served and Its Competitors
Table 89. AstraZeneca Biologic Therapeutic Drug Product Offered
Table 90. AstraZeneca Main Business
Table 91. AstraZeneca Biologic Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. AstraZeneca Latest Developments
Table 93. Pfizer Inc. Details, Company Type, Biologic Therapeutic Drug Area Served and Its Competitors
Table 94. Pfizer Inc. Biologic Therapeutic Drug Product Offered
Table 95. Pfizer Inc. Main Business
Table 96. Pfizer Inc. Biologic Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Pfizer Inc. Latest Developments
Table 98. Merck and Co. Inc. Details, Company Type, Biologic Therapeutic Drug Area Served and Its Competitors
Table 99. Merck and Co. Inc. Biologic Therapeutic Drug Product Offered
Table 100. Merck and Co. Inc. Main Business
Table 101. Merck and Co. Inc. Biologic Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Merck and Co. Inc. Latest Developments
List of Figures
Figure 1. Biologic Therapeutic Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologic Therapeutic Drug Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Biologic Therapeutic Drug Market Size Market Share by Type in 2020
Figure 7. Biologic Therapeutic Drug in Clinical Medicine
Figure 8. Global Biologic Therapeutic Drug Market: Clinical Medicine (2016-2021) & ($ Millions)
Figure 9. Biologic Therapeutic Drug in Laboratory
Figure 10. Global Biologic Therapeutic Drug Market: Laboratory (2016-2021) & ($ Millions)
Figure 11. Biologic Therapeutic Drug in Others
Figure 12. Global Biologic Therapeutic Drug Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Biologic Therapeutic Drug Market Size Market Share by Application in 2020
Figure 14. Global Biologic Therapeutic Drug Revenue Market Share by Player in 2020
Figure 15. Global Biologic Therapeutic Drug Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Biologic Therapeutic Drug Market Size 2016-2021 ($ Millions)
Figure 17. APAC Biologic Therapeutic Drug Market Size 2016-2021 ($ Millions)
Figure 18. Europe Biologic Therapeutic Drug Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Biologic Therapeutic Drug Market Size 2016-2021 ($ Millions)
Figure 20. Americas Biologic Therapeutic Drug Market Size Market Share by Country in 2020
Figure 21. Americas Biologic Therapeutic Drug Market Size Market Share by Type in 2020
Figure 22. Americas Biologic Therapeutic Drug Market Size Market Share by Application in 2020
Figure 23. United States Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Biologic Therapeutic Drug Market Size Market Share by Regions in 2020
Figure 27. APAC Biologic Therapeutic Drug Market Size Market Share by Type in 2020
Figure 28. APAC Biologic Therapeutic Drug Market Size Market Share by Application in 2020
Figure 29. China Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Biologic Therapeutic Drug Market Size Market Share by Country in 2020
Figure 36. Europe Biologic Therapeutic Drug Market Size Market Share by Type in 2020
Figure 37. Europe Biologic Therapeutic Drug Market Size Market Share by Application in 2020
Figure 38. Germany Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Biologic Therapeutic Drug Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Biologic Therapeutic Drug Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Biologic Therapeutic Drug Market Size Market Share by Application in 2020
Figure 46. Egypt Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Biologic Therapeutic Drug Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 52. APAC Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 53. Europe Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 55. United States Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 56. Canada Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 59. China Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 60. Japan Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 61. Korea Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 63. India Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 64. Australia Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 65. Germany Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 66. France Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 67. UK Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 68. Italy Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 69. Russia Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 70. Spain Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 73. Israel Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Biologic Therapeutic Drug Market Size 2021-2026 ($ Millions)
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
